Saragovi H U, Bhandoola A, Lemercier M M, Akbar G K, Greene M I
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
DNA Cell Biol. 1995 Aug;14(8):653-64. doi: 10.1089/dna.1995.14.653.
A novel surface receptor complex involved in inhibition of T-cell proliferation is described. Biochemical isolation revealed two non-covalently associated proteins of about M(r) 65,000 (p65) and 95,000 (p95). These polypeptides may be related. The p65 form is expressed after cellular activation and replication and is recognized by monoclonal antibody (mAb) 87.92.6 or reovirus hemagglutinin as unnatural ligands. The p95 species is associated with tyrosine kinase enzymatic activity. Receptor ligation results in rapid alteration of the phosphotyrosine content of cellular substrates, and this activity correlates with antiproliferative effects. The inhibition of proliferation is a time-dependent reversible arrest at the G1-S phase of the cell cycle. Activation through the T-cell receptor, protein kinase C, or addition of cytokines does not reverse the antiproliferative effect. This receptor complex may define novel features of T-cell proliferation.
本文描述了一种参与抑制T细胞增殖的新型表面受体复合物。生化分离揭示了两种非共价结合的蛋白质,分子量分别约为65,000(p65)和95,000(p95)。这些多肽可能具有相关性。p65形式在细胞活化和复制后表达,可被单克隆抗体(mAb)87.92.6或呼肠孤病毒血凝素识别为非天然配体。p95种类与酪氨酸激酶酶活性相关。受体连接导致细胞底物磷酸酪氨酸含量迅速改变,并且这种活性与抗增殖作用相关。增殖抑制是细胞周期G1-S期的时间依赖性可逆停滞。通过T细胞受体、蛋白激酶C激活或添加细胞因子并不能逆转抗增殖作用。这种受体复合物可能定义了T细胞增殖的新特征。